Q2 is going to be interesting.A little bit of a prediction. Starseed / medical was 5.2m. Substantial growth and the fact we signed so many deals midway through q1 makes me believe we should easily see 6m. Rec I can see dropping a bit, if I'm not mistaken we sold tons of cheap shiskaberry. That being said, I think a conservative 2.5m is appropriate. Now again, during the call they said 40% rec margins 60% medical. This puts us at 4.6m gross, administration fees should be down due to not having a 1m consulting fee. I think that's really the kicker for us. We need margins. Not sure whats dragging them down but honestly even at our current levels this company is only burning 2-3m a quarter if we have our advertised margins. Going with a 8.5-10m rev prediction, margins will probably still Lag and hoping no dilution for the last 5 months is a good sign